Price
No data yet.
Social Signal Score
Revenue
$1.25B+533.25%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Lewis G. Gradon
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 7,661
- Beta
- 0.89
- Country
- NZ
- Piotroski score
- 8 / 9 (Strong)
- Altman Z-score
- 25.17
Financials
Revenue
$1.25B+533.2%Net Income
$258.06M+692.1%EBITDA
$457.04M+679.4%Free Cash Flow
$299.57MEPS (diluted)
$0.44+607.4%Shares Outstanding (diluted)
590.80M+12.8%Operating Expenses
$438.45MCash & Debt
$465.72MReturn of Capital
$112.72MDividend per Share
$0.29Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $2.36B | $473.20M | $0.81 |
| 2025 | $1.28B | $377.20M | $0.64 |
| 2024 | $1.76B | $132.60M | $0.23 |
| 2023 | $1.59B | $250.30M | $0.43 |
| 2022 | $1.64B | $376.90M | $0.65 |
| 2021 | $1.95B | $524.20M | $0.91 |
| 2020 | $1.27B | $287.30M | $0.50 |
| 2019 | $1.12B | $217.93M | $0.39 |
| 2018 | $1.02B | $201.73M | $0.35 |
| 2017 | $947.16M | $184.26M | $0.33 |
| 2016 | $908.34M | $159.17M | $0.29 |
| 2015 | $651.32M | $114.46M | $0.20 |
| 2014 | $612.48M | $104.54M | $0.19 |
| 2013 | $631.90M | $95.99M | $0.17 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from FSPKF's reported EPS growth of 12.5% a year over 13 years.
- EPS in 5 years
- $1.45
- Implied price
- $71.19
- Return from $26.53
- 21.8% a year
To earn 15.0% a year on these assumptions you'd need to buy at $35.39 — today's price is already 25.0% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 35 | 42 | 49 | 56 | 63 |
|---|---|---|---|---|---|
| 2.5% | 3.8% | 7.6% | 11.0% | 14.0% | 16.7% |
| 7.5% | 8.8% | 12.9% | 16.4% | 19.6% | 22.4% |
| 12.5% | 13.9% | 18.1% | 21.8% | 25.1% | 28.1% |
| 17.5% | 19.0% | 23.4% | 27.2% | 30.7% | 33.8% |
| 22.5% | 24.0% | 28.6% | 32.7% | 36.2% | 39.5% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
120Social Signal Score
Mentions (1)
- Newsseekingalpha.com·5h ago·Positive
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Shareholder/Analyst Call Transcript Fisher & Paykel Healthcare Corporation Limited (FSPKF) Shareholder/Analyst Call Transcript
View source ↗
Earnings
Typical surprise +6.0% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, May 26$0.25 vs $0.24beat
- Tue, Nov 25$0.36 vs $0.35beat
- Tue, May 27$0.36 vs $0.34beat
- Thu, Nov 28$0.28 vs $0.29miss
- Tue, May 28$0.26 vs $0.36miss
- Wed, Nov 29$0.20 vs $0.17beat
Estimates and results for FSPKF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.